The global Model Species market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Model Species is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Model Species is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Model Species in Drug Discovery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Model Species include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Model Species, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Model Species.
Report Scope
The Model Species market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Model Species market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Model Species companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
Segment by Type
Rat
Mouse
Zebrafish
Arabidopsis Thaliana
Others
Segment by Application
Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Model Species companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Model Species 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rat
1.2.3 Mouse
1.2.4 Zebrafish
1.2.5 Arabidopsis Thaliana
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Model Species 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Model Species 麻豆原创 Perspective (2019-2030)
2.2 Model Species Growth Trends by Region
2.2.1 Global Model Species 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Model Species Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Model Species Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Model Species 麻豆原创 Dynamics
2.3.1 Model Species Industry Trends
2.3.2 Model Species 麻豆原创 Drivers
2.3.3 Model Species 麻豆原创 Challenges
2.3.4 Model Species 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Model Species Players by Revenue
3.1.1 Global Top Model Species Players by Revenue (2019-2024)
3.1.2 Global Model Species Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Model Species 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Model Species Revenue
3.4 Global Model Species 麻豆原创 Concentration Ratio
3.4.1 Global Model Species 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Model Species Revenue in 2023
3.5 Model Species Key Players Head office and Area Served
3.6 Key Players Model Species Product Solution and Service
3.7 Date of Enter into Model Species 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Model Species Breakdown Data by Type
4.1 Global Model Species Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Model Species Forecasted 麻豆原创 Size by Type (2025-2030)
5 Model Species Breakdown Data by Application
5.1 Global Model Species Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Model Species Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Model Species 麻豆原创 Size (2019-2030)
6.2 North America Model Species 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Model Species 麻豆原创 Size by Country (2019-2024)
6.4 North America Model Species 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Model Species 麻豆原创 Size (2019-2030)
7.2 Europe Model Species 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Model Species 麻豆原创 Size by Country (2019-2024)
7.4 Europe Model Species 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Model Species 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Model Species 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Model Species 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Model Species 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Model Species 麻豆原创 Size (2019-2030)
9.2 Latin America Model Species 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Model Species 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Model Species 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Model Species 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Model Species 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Model Species 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Model Species 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Model Organisms Center, Inc.
11.1.1 Shanghai Model Organisms Center, Inc. Company Detail
11.1.2 Shanghai Model Organisms Center, Inc. Business Overview
11.1.3 Shanghai Model Organisms Center, Inc. Model Species Introduction
11.1.4 Shanghai Model Organisms Center, Inc. Revenue in Model Species Business (2019-2024)
11.1.5 Shanghai Model Organisms Center, Inc. Recent Development
11.2 Gem Pharmatech Co., Ltd.
11.2.1 Gem Pharmatech Co., Ltd. Company Detail
11.2.2 Gem Pharmatech Co., Ltd. Business Overview
11.2.3 Gem Pharmatech Co., Ltd. Model Species Introduction
11.2.4 Gem Pharmatech Co., Ltd. Revenue in Model Species Business (2019-2024)
11.2.5 Gem Pharmatech Co., Ltd. Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Model Species Introduction
11.3.4 Charles River Laboratories Revenue in Model Species Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 Envigo
11.4.1 Envigo Company Detail
11.4.2 Envigo Business Overview
11.4.3 Envigo Model Species Introduction
11.4.4 Envigo Revenue in Model Species Business (2019-2024)
11.4.5 Envigo Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Detail
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Model Species Introduction
11.5.4 Taconic Biosciences Revenue in Model Species Business (2019-2024)
11.5.5 Taconic Biosciences Recent Development
11.6 Jackson Laboratory
11.6.1 Jackson Laboratory Company Detail
11.6.2 Jackson Laboratory Business Overview
11.6.3 Jackson Laboratory Model Species Introduction
11.6.4 Jackson Laboratory Revenue in Model Species Business (2019-2024)
11.6.5 Jackson Laboratory Recent Development
11.7 Shanghai SLAC
11.7.1 Shanghai SLAC Company Detail
11.7.2 Shanghai SLAC Business Overview
11.7.3 Shanghai SLAC Model Species Introduction
11.7.4 Shanghai SLAC Revenue in Model Species Business (2019-2024)
11.7.5 Shanghai SLAC Recent Development
11.8 Joinn Laboratories
11.8.1 Joinn Laboratories Company Detail
11.8.2 Joinn Laboratories Business Overview
11.8.3 Joinn Laboratories Model Species Introduction
11.8.4 Joinn Laboratories Revenue in Model Species Business (2019-2024)
11.8.5 Joinn Laboratories Recent Development
11.9 Crown Biosciences
11.9.1 Crown Biosciences Company Detail
11.9.2 Crown Biosciences Business Overview
11.9.3 Crown Biosciences Model Species Introduction
11.9.4 Crown Biosciences Revenue in Model Species Business (2019-2024)
11.9.5 Crown Biosciences Recent Development
11.10 Pharmalegacy
11.10.1 Pharmalegacy Company Detail
11.10.2 Pharmalegacy Business Overview
11.10.3 Pharmalegacy Model Species Introduction
11.10.4 Pharmalegacy Revenue in Model Species Business (2019-2024)
11.10.5 Pharmalegacy Recent Development
11.11 Syngene International
11.11.1 Syngene International Company Detail
11.11.2 Syngene International Business Overview
11.11.3 Syngene International Model Species Introduction
11.11.4 Syngene International Revenue in Model Species Business (2019-2024)
11.11.5 Syngene International Recent Development
11.12 Janvier Labs
11.12.1 Janvier Labs Company Detail
11.12.2 Janvier Labs Business Overview
11.12.3 Janvier Labs Model Species Introduction
11.12.4 Janvier Labs Revenue in Model Species Business (2019-2024)
11.12.5 Janvier Labs Recent Development
11.13 GenOway
11.13.1 GenOway Company Detail
11.13.2 GenOway Business Overview
11.13.3 GenOway Model Species Introduction
11.13.4 GenOway Revenue in Model Species Business (2019-2024)
11.13.5 GenOway Recent Development
11.14 Psychogenics
11.14.1 Psychogenics Company Detail
11.14.2 Psychogenics Business Overview
11.14.3 Psychogenics Model Species Introduction
11.14.4 Psychogenics Revenue in Model Species Business (2019-2024)
11.14.5 Psychogenics Recent Development
11.15 Horizon Discovery Group
11.15.1 Horizon Discovery Group Company Detail
11.15.2 Horizon Discovery Group Business Overview
11.15.3 Horizon Discovery Group Model Species Introduction
11.15.4 Horizon Discovery Group Revenue in Model Species Business (2019-2024)
11.15.5 Horizon Discovery Group Recent Development
11.16 Vitalstar Biotechnology
11.16.1 Vitalstar Biotechnology Company Detail
11.16.2 Vitalstar Biotechnology Business Overview
11.16.3 Vitalstar Biotechnology Model Species Introduction
11.16.4 Vitalstar Biotechnology Revenue in Model Species Business (2019-2024)
11.16.5 Vitalstar Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
听
听
*If Applicable.
